36C24419Q0778-002.pdf
PDF 157 KB Posted
- Attached to
- (C2) MicroLoop Spirometer System Federal contract opportunity
- Solicitation number
- 36C24419Q0778
About this file
36C24419Q0778 Vmax Encore 22 Work Statemement Pulmonary Function Testing.pdf
View the file
Other files for this federal contract opportunity
| File | Type | Posted |
|---|---|---|
| -17447.docx | DOCX document | |
| 36C24419Q0778-006.docx | DOCX document | |
| 36C24419Q0778-005.docx | DOCX document | |
| 36C24419Q0778-004.docx | DOCX document | |
| 36C24419Q0778-001.docx | DOCX document | |
| 36C24419Q0778-003.pdf | ||
| 36C24419Q0778-000.docx | DOCX document |
On GovTribe
Work with this file on GovTribe
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
CPL Michael J Crescenz VA Medical Center
STATEMENT OF WORK
Requestor/Program Manager
Name: Dr. Frank Austan
Title: Director of Respiratory Care Services
Section: Medicine Service
Address: CMCVAMC Medical Center
3900 Woodland Avenue, Philadelphia, PA 19139
Phone Number: (215) 823‐5800 ex 6281
E‐Mail Address: Frank.Austan@va.gov
VMAX ENCORE VS 22 PULMONARY FUNCTION MESAUREMENT SYSTEM
The Philadelphia’s CMCVA Medical Center is seeking to upgrade its currently used Pulmonary
Function Test (PFT) systems purchased 10 years ago. PFT technology the last 10 years has exponentially evolved into improving accuracy and precision.
The following the working characteristics are expected of a PFT System and are met by the proposed Vmax Encore VS 22 Pulmonary Function Measurement System.
1. Provide stated specification limits for performance (accuracy and precision) for every lung function measurement (Indication for Use) including spirometry (FVC), DLCO, and lung volumes (FRC, plethysmography) as required by the FDA and ISO.
2. Provides end‐users the tools to irrefutably validate the output performance for each of these measurements to the stated specification as required by the FDA and ISO
(International Organization for Standardization) prior to patient testing.
3. Be able to provide the end‐user consistent delivery of valid results for all PFT systems’ clinical indications
4. PFT Unit must be capable of measuring the following:
Spirometry/Pulmonary Function Test
Procedures: Calibration
Pre‐and Post‐Medication Testing
Bronchodilator Overlays
Flow Volume Loops (Forced Vital Capacity)
Lung Subdivisions (Slow Vital Capacity)
Maximum Voluntary Ventilation
Lung Volumes Determination (N2 Method)
Gas Distribution
Closing Volume
Diffusing Capacity‐Single Breath
Diffusing Capacity‐Intra‐Breath. Software
Vision Software Programs Include Extensive Help Menus and Computer Instruction
Tutorial Presentation in a User‐Friendly Microsoft™ Windows Menu Environment
Data Base Management with EZ View and Bar‐Trac Graphic Presentations, Quality Assurance Monitoring
An additional factor of consideration in purchasing Vmax Encore VS 22 Pulmonary Function
System.
| Philadelphia | VA | pulmonologists | and | technologists | are | learned | in | the | operational | use |
| of | this | highly | specialized | equipment. |
RECOMMENDATION
We recommend the purchase of the Vmax Encore 22 Pulmonary Function Testing Equipment, from Care Fusion Respiratory Technologies. POC Gerard Mulholland 714‐922‐7456
Program Need Date May 27th 2019
Location Suites A430 and A431 (4th FL, BLD 1) CMCVA Medical Center 3900 Woodland Avenue 19139 Philadelphia, PA 19139
File details come from the government source that posted it.